article · Nigerian Postgraduate Medical Journal
BACKGROUND: Hypertension is a major non-communicable disease of public health concern. In Nigeria, the rate is between 28% and 42.2%. Hypertension or the prolonged use of some antihypertensive drugs has been associated with hearing loss in studies. There is a paucity of studies on this in our environment. AIMS: Therefore, this study aims to evaluate the relationship between hearing thresholds and hypertension. MATERIALS AND METHODS: This was a hospital-based cross-sectional comparative study of hypertensive and non-hypertensive patients. Ethical approval for the study was obtained. Informed consent was obtained from the participants. A researcher-administered structured pro forma was utilised to obtain demographic and medical history data. Blood pressure measurement and pure-tone audiometry were performed on all the participants. Data were analysed using SPSS version 25. RESULTS: One hundred and twenty-eight participants each were recruited from the hypertensive and control groups for the study. The age range of the hypertension group was 27-60 years. The frequency of hearing loss amongst the hypertension and control groups was 47.7% and 15.6%, respectively (P < 0.001). The mean pure-tone average for the hypertension group was 29.2 dB ± 18.5/28.3 dB ± 20.5 and 21.6 dB ± 8.7/20.6 dB ± 8 in the right and left ears of the hypertensive and control groups, respectively. The frequency of hearing loss in the controlled and uncontrolled hypertensive subjects was 44.7% and 52%, respectively (P = 0.424). Hearing loss frequency was 50% in hypertensive subjects on diuretic and/or beta-blockers and 46% in those on other antihypertensive drugs (P = 0.650). CONCLUSION: The frequency of hearing loss in the hypertension group was significantly higher than in the control group.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/npmj.npmj_136_25
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.